• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov5
Viemed Healthcare released FY2025 9 Months Earnings on November 5 During-Market EST, with actual revenue of USD 194.1 M and EPS of USD 0.2298
21:00
Viemed Healthcare released FY2025 Q3 earnings on November 5 During-Market EST, actual revenue USD 71.91 M (forecast USD 72 M), actual EPS USD 0.0899 (forecast USD 0.095)
21:00
Oct30
Viemed Healthcare to Release FY2025 Q3 Earnings on November 6 During-Market EST, Forecast Revenue USD 72M, EPS USD 0.09
00:34
Aug6
Viemed Healthcare released FY2025 Semi-Annual earnings on August 6 During-Market (EST), actual revenue USD 122.19 M, actual EPS USD 0.1399
20:00
Viemed Healthcare released FY2025 Q2 earnings on August 6 During-Market (EST), actual revenue USD 63.06 M (forecast USD 63.5 M), actual EPS USD 0.0798 (forecast USD 0.09)
20:00
Jul31
Viemed Healthcare to Release FY2025 Q2 Earnings on August 7 During-Market EST, Forecast Revenue USD 63.5 M, EPS USD 0.09
00:36

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 71.91 M, Net Income 3.513 M, EPS 0.0899

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 63.06 M, Net Income 3.157 M, EPS 0.0798

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 59.13 M, Net Income 2.625 M, EPS 0.06

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AFJK
88.500
+1,006.25%
+80.500
OCG
10.270
+291.98%
+7.650
NCPL
1.400
+112.48%
+0.741
LGHL
8.050
+85.91%
+3.720
JXG
8.630
+67.90%
+3.490
ATMVR
1.060
+49.49%
+0.351
DBI
7.200
+48.45%
+2.350
HSPO
17.500
+42.28%
+5.200
CYPH
1.620
+39.66%
+0.460
ALEX
20.850
+37.71%
+5.710
View More